100+ Free FEBU Part 1 Practice Questions

Pass your FEBU Part 1 Written Exam (Fellow of the European Board of Urology) exam on the first try — instant access, no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately

100+ Questions

100% Free

Loading practice questions...

2026 Statistics

Key Facts: FEBU Part 1 Exam

110 questions

Single-correct-answer MCQs covering all urological fields on the Part 1 Written Exam

EBU - FEBU Part 1 Written Exam

No negative marking

Incorrect answers are not penalised, so every question should be attempted

EBU - Important information Part 1 Written Exam

Cohort-based standard setting

Cut-off score derived from the cohort average score and standard deviation

EBU - Important information Part 1 Written Exam

Web-based, proctored

Closed-book exam delivered on assessmentQ and supervised online by ProctorExam

EBU - FEBU Part 1 Written Exam

2 parts

FEBU requires passing both the Part 1 Written and Part 2 Oral exams

EBU - Fellow of the EBU (FEBU)

EBU member country

Participation reserved for candidates trained in an EBU member country

EBU - Important information Part 1 Written Exam

12 November 2026

Scheduled date of the FEBU Part 1 Written Exam in 2026

EBU - FEBU Part 1 Written Exam 2026

100

Free original single-best-answer practice questions here

OpenExamPrep

The FEBU Part 1 Written Exam is a closed-book, web-based test of 110 single-correct-answer multiple-choice questions covering all fields of urology, leading toward the Fellow of the European Board of Urology (FEBU) title. It is delivered remotely on the assessmentQ platform and supervised online by ProctorExam, with no negative marking. EBU applies cohort-based standard setting, so there is no fixed pass percentage; the cut-off is derived from the cohort average and standard deviation. Participation is reserved for candidates trained in an EBU member country, and Part 1 must be passed before the Part 2 Oral Exam. This 100-question bank provides original single-best-answer practice across urological oncology, BPH and LUTS, stone disease, infections, andrology, functional and paediatric urology, trauma, transplantation, pharmacology and imaging.

Sample FEBU Part 1 Practice Questions

Try these sample questions to test your FEBU Part 1 exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 62-year-old man has a 4 cm enhancing solid renal mass found incidentally on CT, confined to the kidney with no nodal or distant spread. What is the cT stage of this tumour under the TNM classification?

A.cT1a

B.cT1b

C.cT2a

D.cT3a

Explanation: Renal tumours 4 cm or less and confined to the kidney are staged cT1a. T1b is >4 to 7 cm, T2 is >7 cm, and T3a indicates invasion of perinephric fat or the renal vein. A 4 cm organ-confined mass is therefore cT1a and is a good candidate for partial nephrectomy.

2Which histological subtype accounts for the majority of renal cell carcinomas and is characterised by frequent loss of the VHL gene on chromosome 3p?

A.Papillary renal cell carcinoma

B.Chromophobe renal cell carcinoma

C.Clear cell renal cell carcinoma

D.Collecting duct carcinoma

Explanation: Clear cell renal cell carcinoma is the most common subtype (about 70-80%) and is strongly associated with loss of the VHL tumour suppressor gene on chromosome 3p, leading to HIF accumulation and angiogenesis. This underlies the activity of anti-angiogenic tyrosine kinase inhibitors in clear cell disease.

3A 70-year-old man has non-muscle-invasive bladder cancer that is high grade and includes carcinoma in situ. After complete transurethral resection, which adjuvant intravesical therapy offers the best protection against progression?

A.Single immediate dose of mitomycin C only

B.Induction and maintenance BCG

C.Intravesical gemcitabine single dose

D.No further therapy, surveillance only

Explanation: For high-risk non-muscle-invasive bladder cancer including CIS or high-grade T1 disease, full-dose induction plus maintenance BCG for at least one year is the recommended adjuvant treatment and reduces both recurrence and progression. A single chemotherapy instillation is insufficient for high-risk disease.

4Under the EAU risk-stratification system for localised prostate cancer, a man with a PSA of 14 ng/mL, ISUP grade group 2 (Gleason 3+4) and clinical stage T2b falls into which risk category?

A.Low risk

B.Intermediate risk

C.High risk

D.Very high risk

Explanation: EAU intermediate-risk localised prostate cancer is defined by a PSA of 10 to 20 ng/mL, or ISUP grade group 2-3, or clinical stage cT2b. This case has all three intermediate features without any high-risk feature, so it is intermediate risk. High risk requires PSA >20, ISUP grade group 4-5, or cT2c or higher.

5A 28-year-old man presents with a painless firm testicular mass and elevated serum AFP and beta-hCG. Which is the correct first surgical step?

A.Trans-scrotal biopsy of the mass

B.Radical inguinal orchidectomy

C.Open testis-sparing enucleation

D.Percutaneous needle biopsy under ultrasound

Explanation: A solid testicular mass with raised tumour markers is presumed malignant and treated with radical inguinal orchidectomy, ligating the cord at the internal ring. A trans-scrotal approach is avoided because it risks altering lymphatic drainage and local seeding.

6In men with localised prostate cancer, multiparametric MRI of the prostate is reported using which standardised scoring system?

A.RENAL nephrometry score

B.PI-RADS

C.Bosniak classification

D.Fuhrman grade

Explanation: Multiparametric prostate MRI is reported with PI-RADS (Prostate Imaging-Reporting and Data System), scoring lesions 1 to 5 for the likelihood of clinically significant cancer. This guides targeted biopsy decisions.

7A 67-year-old man with bothersome LUTS has a prostate volume of 70 mL and a PSA of 3 ng/mL. Which oral medication most directly reduces prostate volume and lowers the long-term risk of acute urinary retention?

A.Tamsulosin

B.Finasteride

C.Solifenacin

D.Mirabegron

Explanation: Finasteride is a 5-alpha-reductase inhibitor that shrinks the prostate over months by blocking conversion of testosterone to dihydrotestosterone, reducing the risk of acute retention and surgery in men with enlarged glands. Alpha-blockers relieve symptoms quickly but do not change prostate size.

8What is the principal mechanism by which alpha-1 adrenergic blockers such as tamsulosin improve male LUTS?

A.Shrinking the prostatic adenoma

B.Relaxing prostatic and bladder neck smooth muscle

C.Blocking muscarinic receptors in the detrusor

D.Inhibiting bacterial growth in the prostate

Explanation: Alpha-1 blockers relax smooth muscle in the prostate, prostatic urethra and bladder neck, reducing dynamic outflow resistance and improving flow within days. They do not alter prostate size or address the static component of obstruction.

9A 45-year-old woman has stress urinary incontinence with urethral hypermobility and has failed pelvic floor training. Which surgical procedure is the standard first-line option with the best long-term evidence?

A.Midurethral synthetic sling

B.Anterior colporrhaphy

C.Sacrocolpopexy

D.Artificial urinary sphincter

Explanation: The midurethral synthetic sling is the most studied and effective surgical treatment for female stress urinary incontinence due to urethral hypermobility, with high cure rates and durable outcomes. It supports the midurethra during increases in abdominal pressure.

10A patient with overactive bladder has not responded to antimuscarinics and a beta-3 agonist. Which is an appropriate next-line therapy?

A.Intradetrusor onabotulinumtoxinA injection

B.Long-term prophylactic antibiotics

C.Bilateral nephrostomy

D.Indwelling urethral catheter

Explanation: After failure of oral therapy for refractory overactive bladder, intradetrusor onabotulinumtoxinA injections or sacral neuromodulation are recommended next-line options. Botulinum toxin reduces detrusor overactivity but carries a risk of incomplete emptying requiring intermittent catheterisation.

About the FEBU Part 1 Exam

The FEBU Part 1 Written Exam is the first of two examinations leading to the title Fellow of the European Board of Urology (FEBU). It is a closed-book, web-based exam of 110 single-correct-answer multiple-choice questions covering the full breadth of urology, delivered remotely on the assessmentQ platform and fully supervised by online proctoring. Participation is reserved for candidates trained in an EBU member country, either within an official national urology training programme or holding a national urology specialist diploma. The exam assesses whether a candidate meets the minimum knowledge level set by the EBU, with cohort-based standard setting and no negative marking. Passing Part 1 is required before sitting the Part 2 Oral Exam.

Assessment

110 single-correct-answer multiple-choice questions covering all urological fields. The European Board Examinations in Urology have two parts: Part 1 Written Exam and Part 2 Oral Exam; this bank covers only Part 1.

Time Limit

A single timed, supervised web-based session. EBU publishes the exact duration and start time in the candidate instructions for each exam date.

Passing Score

No fixed pass percentage. EBU applies cohort-based standard setting, with the cut-off derived from the cohort's average score and standard deviation. There is no negative marking, so candidates should answer every question.

Exam Fee

The EBU sets and publishes a registration fee for each exam cycle on its website; confirm the current fee, candidate category and payment deadline when you register. (European Board of Urology (EBU), delivered via assessmentQ (Televic) with ProctorExam online proctoring)

FEBU Part 1 Exam Content Outline

30%

Urological oncology

Renal cell carcinoma, urothelial carcinoma of the bladder and upper tract, prostate cancer, testicular germ cell tumours and penile cancer: epidemiology, histology, TNM staging, risk stratification, surgical management and systemic therapy aligned with current EAU Guidelines.

18%

BPH, LUTS and functional urology

Benign prostatic obstruction and male LUTS, female LUTS and stress incontinence, overactive bladder, neurogenic lower urinary tract dysfunction, urodynamics, pelvic organ prolapse and the medical and surgical management of voiding and storage disorders.

12%

Stone disease and endourology

Pathophysiology and metabolic evaluation of urolithiasis, stone composition, indications for SWL, ureteroscopy and percutaneous nephrolithotomy, and the emergency management of obstructing and infected stones.

15%

Infections, andrology and infertility

Urinary tract infections, prostatitis, urosepsis, sexually transmitted infections, Fournier gangrene, male infertility evaluation, erectile dysfunction, hypogonadism, Peyronie disease and priapism.

12%

Paediatric urology, trauma and transplantation

Congenital anomalies, vesicoureteral reflux, undescended testis, posterior urethral valves, hypospadias, genitourinary trauma grading and management, renal transplantation and post-transplant urological complications.

13%

Anatomy, physiology, pharmacology and imaging

Genitourinary surgical anatomy, renal and bladder physiology, urological pharmacology including alpha-blockers, antimuscarinics, 5-alpha-reductase inhibitors and chemotherapeutic agents, and the indications and interpretation of ultrasound, CT, MRI and nuclear medicine in urology.

How to Pass the FEBU Part 1 Exam

What You Need to Know

Passing score: No fixed pass percentage. EBU applies cohort-based standard setting, with the cut-off derived from the cohort's average score and standard deviation. There is no negative marking, so candidates should answer every question.
Assessment: 110 single-correct-answer multiple-choice questions covering all urological fields. The European Board Examinations in Urology have two parts: Part 1 Written Exam and Part 2 Oral Exam; this bank covers only Part 1.
Time limit: A single timed, supervised web-based session. EBU publishes the exact duration and start time in the candidate instructions for each exam date.
Exam fee: The EBU sets and publishes a registration fee for each exam cycle on its website; confirm the current fee, candidate category and payment deadline when you register.

Keys to Passing

Complete 500+ practice questions
Score 80%+ consistently before scheduling
Focus on highest-weighted sections
Use our AI tutor for tough concepts

FEBU Part 1 Study Tips from Top Performers

1Base your preparation on the current EAU Guidelines, since the EBU expects up-to-date knowledge of guideline recommendations across every urological subspecialty.

2Because there is no negative marking, answer every question and make an educated guess on items you are unsure about rather than leaving blanks.

3Drill oncology heavily: kidney, bladder, prostate, testis and penile cancer staging and management make up the largest share of the exam.

4Practise interpreting imaging and pathology descriptions, as many single-best-answer items hinge on recognising a classic CT, MRI or histology pattern.

5Learn key numbers cold: PSA thresholds, TNM stages, stone-size cut-offs for treatment, and standard drug doses and mechanisms.

6Do timed mixed-topic question sets to build the rapid pattern recognition needed for a 110-item single-session written exam.

Frequently Asked Questions

How many questions are on the FEBU Part 1 Written Exam?

The Part 1 Written Exam consists of 110 single-correct-answer multiple-choice questions covering all urological fields. There is no negative marking, so candidates should attempt every question.

How is the FEBU Part 1 exam delivered?

It is a closed-book, web-based exam taken remotely on the assessmentQ platform (Televic) and fully supervised online by ProctorExam invigilation. Candidates need a suitable computer, webcam and stable internet connection.

What is the passing score for FEBU Part 1?

There is no fixed pass percentage. EBU applies cohort-based standard setting, deriving the cut-off score from the cohort's average score and standard deviation, so the threshold varies between exam cohorts.

Who is eligible to sit the FEBU Part 1 exam?

Participation is reserved for candidates trained in an EBU member country, either within an official national urology training programme or holding a national urology specialist diploma issued in an EBU member country. Check the EBU website for the exact eligibility deadlines each year.

How does Part 1 relate to the FEBU title?

The FEBU title requires passing both Part 1 (Written) and Part 2 (Oral). Candidates must pass the Part 1 Written Exam before they are allowed to sit the Part 2 Oral Exam.

Are these official EBU exam questions?

No. These are original OpenExamPrep practice questions modelled on the FEBU Part 1 format and content areas. The EBU does not release its actual exam questions; use the EAU Guidelines and standard urology textbooks alongside this practice.